February 24, 2005
The researchers developed a three-dimensional image of the protein gp120, which is part of HIV's membrane, before it metamorphoses itself and attaches to a cell's CD4 receptors. After gp120 attaches to the receptors, HIV is able to penetrate the cell's interior and reproduce.
"Knowing how gp120 changes shape is a new route to inhibiting HIV by using compounds that inhibit the shape change. The findings will also help us understand why it's so hard to make an HIV vaccine, and will help us start strategizing about new approaches to vaccine development," Harrison said.
A key focus of the conference is vaccine treatments that stimulate the body, at the cellular level, to defend itself. Yet despite the promise of such cellular vaccines, real prevention of HIV's attack requires stimulating the immune system to produce virus-destroying antibodies before HIV enters cells, said Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases. "A safe and effective HIV vaccine is critical to the control of HIV globally, and is the most important and difficult scientific challenge facing AIDS researchers today," Fauci said.
Agence France Presse
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.